Dysport® Adult Lower Limb Spasticity Follow-on Study
- 26 Juin 2024 - 1 mn de lecture
The purpose of this research study is to assess the long term safety of Dysport in hemiparetic subjects with lower limb spasticity due to stroke or traumatic brain injury over repeated treatment cycles.
26 Juin 2024
1 mn de lecture
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
26 Juin 2024
1 mn de lecture
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
26 Juin 2024
1 mn de lecture
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
26 Juin 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
26 Juin 2024
1 mn de lecture
Dysport® Pediatric Lower Limb Spasticity Study
26 Juin 2024
1 mn de lecture
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
26 Juin 2024
1 mn de lecture
Dysport® Adult Lower Limb Spasticity Study
26 Juin 2024
1 mn de lecture
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
26 Juin 2024
1 mn de lecture
Dysport in the Treatment of Glabellar Lines in Chinese Subjects
26 Juin 2024
1 mn de lecture